Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01683188
Title HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Prometheus Laboratories
Indications

melanoma

Therapies

Aldesleukin + Vemurafenib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University Arizona Cancer Center Tucson Arizona 85719 United States Details
Moores UCSD Cancer Center La Jolla California 92093 United States Details
MSMC Research Program Miami Beach Florida 33140 United States Details
Emory University School of Medicine Atlanta Georgia 30322 United States Details
Loyola University Medical Center, Div of Hematology/Oncology Maywood Illinois 60153 United States Details
Luther General Cancer Care Institute Park Ridge Illinois 60068 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
University of Kansas Kansas City Kansas 66160-0003 United States Details
Hematology/Oncology Clinic Baton Rouge Louisiana 70809 United States Details
University of Michigan, Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University of Minnesota Masonic Cancer Center Minneapolis Minnesota 55455 United States Details
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
The Christ Hospital Cancer Center Cincinnati Ohio 45219 United States Details
Case Comprehensive Cancer Center Cleveland Ohio 44106 United States Details
Providence Cancer Center Portland Oregon 97213 United States Details
St. Luke's Hospital, Anderson Campus Easton Pennsylvania 18045 United States Details
UPMC Cancer Centers Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field